JUNO
Juno Therapeutics, Inc.
JUNO
JUNO
Delisted
JUNO was delisted on the 5th of March, 2018.
132 hedge funds and large institutions have $2.17B invested in Juno Therapeutics, Inc. in 2015 Q3 according to their latest regulatory filings, with 35 funds opening new positions, 54 increasing their positions, 28 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
34% less call options, than puts
Call options by funds: $29.5M | Put options by funds: $44.9M
38% less first-time investments, than exits
New positions opened: 35 | Existing positions closed: 56
Holders
132
Holding in Top 10
3
Calls
$29.5M
Puts
$44.9M
Top Buyers
| 1 | +$121M | |
| 2 | +$34.8M | |
| 3 | +$26.9M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$22M |
| 5 |
State Street
Boston,
Massachusetts
|
+$13.3M |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$14.9M | |
| 3 | -$14.4M | |
| 4 |
JPMorgan Chase & Co
New York
|
-$12.3M |
| 5 |
DM
Deerfield Management
New York
|
-$9.77M |